Dolutegravir in Pregnant HIV Mothers and Their Neonates
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 05 Oct 2018
At a glance
- Drugs Dolutegravir (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- Acronyms DolPHIN-2
- 25 Sep 2018 Status changed from recruiting to active, no longer recruiting.
- 23 Jan 2018 Status changed from not yet recruiting to recruiting.
- 16 Aug 2017 New trial record